Emcure Pharmaceuticals
EMCURE · Pharma > Pharmaceuticals & Drugs Listing date: July 10, 2024

Stock Price vs Company Growth
1d
2.6%
1w
1.6%
1m
5.8%
3m
6.3%
6m
0.3%
1y
36.2%
all
4.7%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 1,459 2.6%
1,325
1,586
Company Overview

Sales
8,850 Cr
Growth: 14.6%
Profit after Tax
870 Cr
Growth: 9.7%
Mid Cap
27,662 Cr
P/E: 31.8x
Industry P/E: 29.7x
Fundamentals

Sales (Cr) ₹ 8,850
Growth 14.6%
EBITDA 19.8%
P/S 3.1x
Dividend 0.0%
P/E 31.8x
Book Value ₹ 270
PEG Ratio 2.2x
ROE 18.2%
P/B 5.4x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

Emcure Pharmaceuticals is one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. The company’s core strength and competitive advantage lie in its established presence in all major therapeutic areas including Gynaecology, cardiology, blood-related, oncology, respiratory, CNS & HIV among others.
Followers (1)